Page last updated: 2024-10-28

hydralazine and Carcinoma 256, Walker

hydralazine has been researched along with Carcinoma 256, Walker in 1 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"5-Fluorouracil was added into the diffusion cell in combination with vasomodulators or after pretreatment with epinephrine."1.46Influence of vasomodulators and tumor transplantation on the disposition of 5-fluorouracil after application to the liver surface in rats. ( Fumoto, S; Horishita, M; Kodama, Y; Miyamoto, H; Nakamura, J; Nishida, K; Sasaki, H; Tokunaga, A, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kodama, Y1
Horishita, M1
Tokunaga, A1
Miyamoto, H1
Fumoto, S1
Sasaki, H1
Nakamura, J1
Nishida, K1

Other Studies

1 other study available for hydralazine and Carcinoma 256, Walker

ArticleYear
Influence of vasomodulators and tumor transplantation on the disposition of 5-fluorouracil after application to the liver surface in rats.
    Biopharmaceutics & drug disposition, 2017, Volume: 38, Issue:6

    Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma 256, Walker; Cell Line, Tumor; Epinephrine; Fluo

2017